Search Results
Alok A. Khorana: Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients
Rivaroxaban for thromboprophylaxis in high-risk cancer patients: CASSINI results
Alok Khorana: Rivaroxaban Prevents Cancer-Associated VTE
Rivaroxaban in Cancer-Associated VTE: Results from CALLISTO
Rivaroxaban for Thromboprophylaxis in High Risk Ambulatory Patients with Cancer
VTE Prevention in Cancer Patients - Alok A. Khorana, MD
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with cancer
Rivaroxaban for thromboprophylaxis in high risk ambulatory patients with cancer
CASSINI: can we prevent thrombosis in cancer patients who are at risk?
Dalteparin Thromboprophylaxis in Cancer Patients
Dr. Khorana on Current Practice Patterns on Anticoagulant Treatments for Thrombosis
Cancer and Thrombosis - Alok A. Khorana, MD
